BESSEMER GROUP INC

Position in ACAD — Acadia Pharmaceuticals Inc

CIK 1054074 WOODBRIDGE, NJ

Position in ACAD

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$3,802,817

+$452,733 QoQ

Shares Held

150,309

-0.1% QoQ

Ownership

0.087%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#85

of 354 holders

Holding Since

Dec 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

BESSEMER GROUP INC holds $406,590,287 across 94 Biotechnology names. ACAD ranks #16 (0.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	267,779	$248,437,315
2	LGND	Ligand Pharmaceuticals Inc	141,449	$44,708,085
3	MAZE	Maze Therapeutics, Inc.	481,790	$14,376,613
4	TNGX	Tango Therapeutics, Inc.	354,206	$11,072,479
5	RLAY	Relay Therapeutics, Inc.	457,869	$8,566,728
6	KRYS	Krystal Biotech, Inc.	20,285	$7,539,324
7	NRIX	Nurix Therapeutics, Inc.	306,003	$7,423,632
8	TGTX	Tg Therapeutics, Inc.	132,555	$7,280,868

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,802,817	150,309	-0.1%	Shares	Defined	2026-08-12
2026-03-31	$3,350,084	150,498	+21126.8%	Shares	Defined	2026-05-06
2025-12-31	$18,936	709	+18.4%	Shares	Defined	2026-02-05
2025-09-30	$12,782	599	+68.7%	Shares	Defined	2025-11-05
2025-06-30	$7,657	355	-27.6%	Shares	Defined	2025-08-01
2025-03-31	$8,138	490	+553.3%	Shares	Defined	2025-04-23
2024-09-30	$1	75	-60.7%	Shares	Defined	2024-11-12
2022-03-31	$4,626	191	0.0%	Shares	Defined	2022-05-12
2021-12-31	$4,457	191	0.0%	Shares	Defined	2022-01-27
2021-09-30	$3,172	191	0.0%	Shares	Defined	2021-11-12
2021-06-30	$4,658	191	0.0%	Shares	Defined	2021-08-06
2021-03-31	$4,927	191	—	Shares	Defined	2021-05-13
2020-12-31	$0	0	—	Shares	Defined	2021-02-09
No filing history on record for this holder in this stock.